Back to
Jefferies Financial Group Inc.
KNTE
Showing 0 of 4 quarters
Position history for
Jefferies Financial Group Inc.'s holdings in KINNATE BIOPHARMA INC
As of its Q1 2024 13F, Jefferies Financial Group held 40,500 shares of KNTE (Kinnate Biopharma), worth $107,730. Jefferies Financial Group's 13F filings listed KNTE from Q3 2023 to Q1 2024, 3 quarterly filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of KNTE: RA Capital Management, L.P., FMR LLC